Kymera Therapeutics Inc. to Participate in Stifel Virtual Immunology and Inflammation Forum

Reuters
2025.08.27 11:00
portai
I'm PortAI, I can summarize articles.

Kymera Therapeutics Inc. will participate in the Stifel 2025 Virtual Immunology and Inflammation Forum on September 15 at 12:30 p.m. ET. The company, known for developing oral small molecule degrader medicines for immunological diseases, will engage in a fireside chat. Live webcasts will be available on their website, with replays post-event. This news was generated by Public Technologies and is for informational purposes only.

Kymera Therapeutics Inc. will participate in the Stifel 2025 Virtual Immunology and Inflammation Forum on September 15 at 12:30 p.m. ET. The company, known for developing oral small molecule degrader medicines for immunological diseases, will be part of a fireside chat at this event. Live webcasts of the presentation will be accessible on their website, with replays available after the event. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kymera Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9518599-en) on August 27, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.